Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Buoyant market for magnetic resonance imaging (MRI) contrast media in Japan:

This article was originally published in Clinica

Executive Summary

The Japanese market for MRI contrast media is worth around ¥0,000 million ($91 million) at official reimbursement prices, estimates Japan Medical Review. This is forecast to rise to Yen17,000 million by 1998, reflecting the expected growth of MRI scanning and increase in the number of scanners in Japan. Daiichi, which recently launched Nycomed's MRI contrast agent, Omniscan, in Japan (see Clinica No 713, p 9), estimates Omniscan sales will total Yen1,500 million in its first year on the market, rising to Yen4,000 million by 1998.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT088719

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel